CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding CalciMedica, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 25 | 27 | +2 |
| Shares | 10.8M | 11.9M | +1.12M (+10.4%) |
| Value | $10.2M | $5.97M | −$4.20M (−41.3%) |
New holders (5)
Institutions that held CalciMedica, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BML Capital Management, LLC | 1,235,943 | $618.0K | 0.59% |
| Belvedere Trading LLC | 5,300 | $2.65K | 0.00% |
| Advisory Services Network, LLC | 631 | $316 | 0.00% |
| Bank of America Corp | 44 | $22 | 0.00% |
| GWM Advisors LLC | 1,000 | $1 | 0.00% |
Sold out (3)
Institutions that held CalciMedica, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jane Street Group, LLC | 11,455 | $11.0K |
| BNP Paribas Arbitrage, SA | 114 | $107 |
| JPMorgan Chase & Co | 7 | $0 |